New Key Statistics Module, Z-Score and F-Score
NAS:CNTB Key Ratios
| Market Cap $ M | 61.88 |
| Enterprise Value $ M | -47.41 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 0.80 |
| Price/Book | 0.57 |
| Price/Sales | 2.60 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 24.00 |
| EPS (TTM) $ | -0.39 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 2.23 |
| EV-to-EBITDA | 2.34 |
| PEG | -- |
| Shares Outstanding M | 55.25 |
| Net Margin (%) | -88.66 |
| Operating Margin % | -109.85 |
| Pre-tax Margin (%) | -88.17 |
| Quick Ratio | 12.04 |
| Current Ratio | 12.04 |
| ROA % (ttm) | -16.45 |
| ROE % (ttm) | -18.88 |
| ROIC % (ttm) | -269.90 |
| Dividend Yield % | -- |
| Altman Z-Score | -- |
CNTB Number of Guru Trades
CNTB Volume of Guru Trades
Gurus Latest Trades with NAS:CNTB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CNTB is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Connect Biopharma Holdings Ltd Insider Transactions
No Available Data
News about NAS:CNTB
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers